Leandro Venturutti

894 total citations
16 papers, 516 citations indexed

About

Leandro Venturutti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Leandro Venturutti has authored 16 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Leandro Venturutti's work include Cytokine Signaling Pathways and Interactions (5 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Leandro Venturutti is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Leandro Venturutti collaborates with scholars based in Argentina, United States and Chile. Leandro Venturutti's co-authors include Roxana Schillaci, Patricia V. Elizalde, Martín A. Rivas, Ari Melnick, Cecilia J. Proietti, Juan Carlos Roa, Pablo Guzmán, María F. Mercogliano, Tim H.‐M. Huang and Yi‐Wen Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Cell.

In The Last Decade

Leandro Venturutti

15 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leandro Venturutti Argentina 10 316 216 174 82 78 16 516
Adam Nopora Germany 10 235 0.7× 124 0.6× 114 0.7× 68 0.8× 76 1.0× 23 420
Roza Zandi Denmark 7 324 1.0× 264 1.2× 103 0.6× 41 0.5× 62 0.8× 9 540
Hendrika M. Oosterkamp Netherlands 9 214 0.7× 200 0.9× 191 1.1× 33 0.4× 61 0.8× 26 441
Martina Brandl Germany 9 354 1.1× 273 1.3× 96 0.6× 30 0.4× 69 0.9× 12 527
Marloes E.C. Broekmans Netherlands 11 302 1.0× 334 1.5× 123 0.7× 29 0.4× 173 2.2× 13 723
Lucia Nobili Italy 15 385 1.2× 120 0.6× 136 0.8× 124 1.5× 54 0.7× 24 597
Samar Alsafadi France 12 525 1.7× 151 0.7× 126 0.7× 36 0.4× 22 0.3× 24 672
Josephine Iaria Australia 11 308 1.0× 203 0.9× 92 0.5× 27 0.3× 31 0.4× 14 459
Teresa Paíno Spain 14 443 1.4× 227 1.1× 94 0.5× 96 1.2× 18 0.2× 31 629
Jennie Hauser United States 9 332 1.1× 235 1.1× 94 0.5× 73 0.9× 38 0.5× 13 542

Countries citing papers authored by Leandro Venturutti

Since Specialization
Citations

This map shows the geographic impact of Leandro Venturutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leandro Venturutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leandro Venturutti more than expected).

Fields of papers citing papers by Leandro Venturutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leandro Venturutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leandro Venturutti. The network helps show where Leandro Venturutti may publish in the future.

Co-authorship network of co-authors of Leandro Venturutti

This figure shows the co-authorship network connecting the top 25 collaborators of Leandro Venturutti. A scholar is included among the top collaborators of Leandro Venturutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leandro Venturutti. Leandro Venturutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Michael Y., Lauren C. Chong, Gerben Duns, et al.. (2024). TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 121(18). e2320421121–e2320421121. 7 indexed citations
2.
Zamponi, Nahuel, Hasini Jayatilaka, Bartholomew Starich, et al.. (2024). Profiling Dynamic Patterns of Single‐Cell Motility. Advanced Science. 11(38). e2400918–e2400918. 4 indexed citations
3.
4.
Li, Michael Y., Lauren C. Chong, Bruce W. Woolcock, et al.. (2022). TRAF3 Loss-of-Function Reveals the Non-Canonical NF-Κb Pathway As a Therapeutic Target in Diffuse Large B-Cell Lymphoma. Blood. 140(Supplement 1). 2042–2043.
5.
Béguelin, Wendy, Matt Teater, Cem Meydan, et al.. (2020). Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. Cancer Cell. 37(5). 655–673.e11. 83 indexed citations
6.
Venturutti, Leandro & Ari Melnick. (2020). The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs. Blood. 136(20). 2263–2274. 27 indexed citations
7.
Venturutti, Leandro & Ari Melnick. (2020). The Role of Epigenetic Mechanisms in B Cell Lymphoma Pathogenesis. 5(1). 311–330. 3 indexed citations
8.
Mercogliano, María F., Mara De Martino, Sofía Bruni, et al.. (2017). Abstract 1195: TNFα induces multiresistance to HER2-targeted TNFα induces multiresistance to HER2-targeted therapies in HER2-positive breast cancer. Cancer Research. 77(13_Supplement). 1195–1195. 1 indexed citations
9.
Mercogliano, María F., Mara De Martino, Leandro Venturutti, et al.. (2016). TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer. Clinical Cancer Research. 23(3). 636–648. 81 indexed citations
10.
Venturutti, Leandro, Rosalía I. Cordo Russo, Martín A. Rivas, et al.. (2016). MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene. 35(48). 6189–6202. 74 indexed citations
11.
Venturutti, Leandro, Alejandro J. Urtreger, Rosalía I. Cordo Russo, et al.. (2015). Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. Oncogene. 35(17). 2208–2222. 51 indexed citations
12.
Proietti, Cecilia J., Franco Izzo, María C. Díaz Flaqué, et al.. (2015). Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth. Molecular Endocrinology. 29(10). 1468–1485. 12 indexed citations
13.
Russo, Rosalía I. Cordo, Wendy Béguelin, María C. Díaz Flaqué, et al.. (2014). Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance. Oncogene. 34(26). 3413–3428. 42 indexed citations
14.
Izzo, Franco, María F. Mercogliano, Leandro Venturutti, et al.. (2014). Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Research. 16(6). 491–491. 27 indexed citations
15.
Venturutti, Leandro, Ernesto A. Román, Cristina Marino‐Buslje, et al.. (2013). The role of the N‐terminal tail for the oligomerization, folding and stability of human frataxin. FEBS Open Bio. 3(1). 310–320. 10 indexed citations
16.
Rivas, Martín A., Leandro Venturutti, Yi‐Wen Huang, et al.. (2012). Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Research. 14(3). R77–R77. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Nopora Breakdown of academic impact, for papers by Roza Zandi Breakdown of academic impact, for papers by Hendrika M. Oosterkamp Breakdown of academic impact, for papers by Martina Brandl Breakdown of academic impact, for papers by Marloes E.C. Broekmans Breakdown of academic impact, for papers by Lucia Nobili Breakdown of academic impact, for papers by Samar Alsafadi Breakdown of academic impact, for papers by Josephine Iaria Breakdown of academic impact, for papers by Teresa Paíno Breakdown of academic impact, for papers by Jennie Hauser
Rankless by CCL
2026